5.28 USD
▲+0.17+1.73%
盘后 5.62 +8.29%
2026-08-03
市值
$67.47M
市盈率
—
EPS
-3.17
股息率
—
52 周区间
3.50 – 13.50
成交量
45.98K
Beta
0.92
目标价
32.20
52W 低 3.5052W 高 13.50
价格走势
公司简介
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company’s lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinde...